药学专业实验室建设与改革初探

实验室是开展科学研究、培养高素质和创新性人才的基地,实验室建设则是学科建设的重要组成部分.针对目前实验室建设中普遍存在的弊端,结合本校药学实验中心的实际情况,就实验室管理体制改革、实验教学改革、考核模式改革以及实验队伍建设等进行了思考和探索.     

药学监护对于医院质量管理的提高作用及实施策略

目的 探讨药学监护对于医院质量管理的提高作用,并分析相应实施策略.方法 回顾性分析我单位药学监护实施以来在医院质量管理提高中的作用,并归纳分析实施策略.结果 药学监护作为一项新兴药学模式,能够显著加强药学质量监督,减少不良反应发生,改善医院药物质量控制.结论 临床药学从业人员应当重视药学服务在医院工作中的地位,努力提高自身素质,迅速适应药学服务模式的改变,加强理论工作与服务实践的结合,从而达到提高药学服务质量,提高医院质量管理的目的.     

高职药学专业学生实践技能的培养

在高职药学教育中,学生实践技能的培养是非常重要的一个教学环节.本文从“工学结合”的才培养模式的实施、建设稳定的药学实践教学基地、以实践技能掌握为主线来重组实训内容、改革教学方法和手段、建立实训教学效果的考评体系和加强实习教学环节等几个方面探讨如何培养药学专业学生的实践技能.突出学生实践技能的培养,是社会发展的必然趋势,...     

基于海南健康岛需求的创新型药学人才的培养

海南大学药学院基于海南健康岛建设对药学人才的需求，综合改革药学专业本科教学模式，将思想政治教育渗透进专业知识教育，将基础知识教育融合课外实践教育，在共性教育中突出学生个性教育，在从严管理中结合教师的人格感化，探索集思想指引、知识引领、生活关心、心理关怀、职业规划于一体的教育机制。多方面、多层次、多角度对药学生进行全面培养与教育，培养具有创造力的药学专业人才。     

医学教育创新发展中药学学科大型仪器实验平台精准化管理探索

精密仪器实验室建设的成效直接影响未来高端药学人才的培养、学科的建设和学校的发展.受历史原因影响以及管理制度的制约,精密仪器实验平台的管理存在诸多问题.本文结合各种影响因素,从人力、物力、管理以及现代化、产业化等方面考虑,提出了在管理体系、信息化、产学研等方面针对这些问题的精准化策略.     

医院药学工作中存在的问题及对策

为探讨医院药学管理中存在的问题及对策,建立医院药学规范化建设的途径,提高医院药学服务质量。依据《医疗机构药事管理规定》,探讨现代医院的创新管理模式,提出适合医院发展的药学管理方法。找到创建现代医院药学管理系统、药学服务系统、药品供应保障系统、合理用药咨询系统、人才培训和绩效考核系统等6大建设要素。6大建设要素对指导医院规范管理与建设现代化医院药学,提高医院药学服务质量有很好的参考作用。     

美国药学工作范围对我国的启示

目的 为我国药学工作发展提供参考.方法 查阅美国药学工作管理相关网络信息,介绍现阶段美国药学实践的范围.结果 美国药学工作范围已从传统的药品调剂、药物咨询、临床药学服务发展到社区、临终关怀中心以及远程药学服务等多方面.结论 药学工作范围将逐步扩大,药学服务将在健康保健体系中占据着重要位置.我国应加强适于多领域药学服务型人才的培养与管理.     

药学管理工作中药学监护存在的问题及其对策

目的:探讨药学管理工作中药学监护存在的问题及其解决对策.方法:对医疗机构的药学监护工作现状进行分析、并对药学监护中存在的问题进行研究,针对药学监护中存在的问题,提出有效对策.结果:目前,医疗单位药学管理工作中对药学监护缺乏正确认识、药学监护制度不健全、医院药房缺乏合理的管理方法、药师对药学管理工作的认识和社会对此的需求不足,都是现代药学监护中存在的主要问题.结论:药学监护在药学管理的工作实践中存在一系列问题,健全药学监护制度、转化药学服务模式、培养药学管理人才等都是促进药学监护工作顺利开展的关键因素.     

关于召开全国医院药师药学保健研讨会的通知

为探讨在医院开展药学保健的必要性和实施办法,充分研究发挥药师的职责和作用,促进医院药学建设与发展,中华医院管理学会药事管理专业委员会拟定于1999年5月上旬在四川省成都市召开全国医院药师药学保健研讨会.一、征文内容:①药学保健的含义、内容、意义、任务、实施办法和困难;②医院药师在药学保健工作中的作用与地位;③医院临床药师的培养与临床实践;④药学保健与临床药学的相互关系与区别,基层医疗单位开展临床药学工作的思路与实践;⑤实现临床安全、有效、经济用药的难点与具体措施办法;③“医药分业”[实为医药分离(分家)]对医院药学建设与发展以及对医院医疗质量、医疗水平的影响.二、征文要求:①文稿必须正楷书写,中、外文要清晰、准确.务求论点明确、文字精练,全文在3500字以下,并需附约500字的摘要一份.②文稿请注明作者姓名、单位、地址、邮编,并须加盖单位公章.③凡已在全国公开刊物上发表和在全国各学术会议上交流过的论文不再选用.     

现代医院药学运管模式的创新设计

目的:探讨现代医院药学的创新运管模式。方法:依据国家颁发的《医疗机构药事管理暂行规定》、《医院分级管理评判标准》、《中医医院管理评价指南》和《医疗机构制剂配制质量管理规范》等技术要求,结合现代医院药学的运作特点与科学规律,应用系统管理理论,对影响医院药学建设的相关因素进行了研究。结果:找到了创建现代医院药学管理系统、药学服务系统、制剂生产研制系统、药品供应质保系统、合理用药咨询系统、人才培养与绩效考核系统等6大建设要素。结论:对指导各地规范管理与建设现代化医院药学有着十分重要的参考作用。     

临床药学专业实习教育机制探索

临床药学专业实习教育是高等临床药学专业教育的重要组成部分，是将药学和医学知识融会贯通的重要阶段，是培养临床药学实践技能、提高综合素质的关键时期。抓好实习教育将有利于临床药学专业学生的培养和市场要求。从临床药学专业实习教育的各个环节包括实习基地建设、实习管理和毕业论文写作方面作了详细介绍。     

基于PBL的临床中药学实训教学

临床中药学教学质量直接影响学生使用中药的能力,关系到中药临床应用的安全性、有效性及合理性。临床中药学实训教学就是要通过直观的、生动的、启发性的实践训练,强化学生的识药能力、对药性理论的融会贯通思维能力和辨证用药能力。在实训中,借助“模拟药房”载体,以药性理论为指导设计有意义的问题情境,引入PBL教学,以问题为主线,打破学科分界,贯通理法方药,结合教学案例探讨PBL教学模式在中药学教学中的应用。     

Health,wealth and the way we live now

The 9th Health Services Research and Pharmacy Practice Conference was hosted by the clinical and practice research group at the School of Pharmacy, Queen's University Belfast, Northern Ireland, on April 14 and 15, 2003. The opening plenary address focused on the influence that social environment has on health. Imogen Savage reports on this and on some of the other research presented at the conference.     

生物类似药临床应用的循证评价及循证指南制定方案

生物类似药的临床应用面临诸多问题,临床长期应用的有效性与安全性监测、未获批适应证的外推应用、互换用药及药物警戒等方面亟待规范。目前国内外尚无基于循证医学证据的生物类似药用药指南,制定一部循证指南对规范生物类似药的临床全流程应用十分必要。本文对现有生物类似药相关指导文件和系统评价进行全面检索与循证分析,结合生物类似药临床应用现状,对《中国生物类似药临床应用循证指南》制定方案进行详细介绍。本指南由北京大学第三医院药剂科发起,中国药学会循证药学专业委员会、中国药学会医院药学专业委员会、中国药理学会治疗药物监测研究专业委员会、海峡两岸医药卫生交流协会医院药学专业委员会批准制定。指南已在国际实践指南注册平台注册,注册号：IPGRP-2020CN172。指南制定过程将基于循证医学证据,严格参照世界卫生组织指南制定手册的制定步骤,参考美国医学研究所最新指南定义、GRADE工具、指南研究与评价工具及卫生保健实践指南报告条目标准,并由多学科多地域专家共同完成。本指南的制定旨在为生物类似药临床应用全流程提供循证指导,以提高生物类似药用药的安全性、有效性与经济性。     

Arguments for theory‐based Pharmacy Practice research

The aim of this discussion paper is to argue for the relevance of theory use in Pharmacy Practice research and to stimulate debate about the quality and relevance of research carried out in this field. A general definition of the concept of “theory” is provided, and the paper discusses the advantages of theory‐based Pharmacy Practice research. The number and range of theories useful for Pharmacy Practice research are enormous and varied, originating from such fields as sociology, psychology, anthropology, pedagogy and health economics. The paper describes how methods that follow specific theories can serve different purposes. We suggest that engaging with theory provides richer and deeper insights into human behaviour and its social context, which can ultimately contribute to dynamism and diversity in Pharmacy Practice research. Examples are presented from projects carried out in the school of pharmacy in Copenhagen and the school of pharmacy and pharmaceutical sciences at the University of Manchester in order to illustrate the different functions of theory in Pharmacy Practice research.     

Improving prescribing,and violence at work

A conference on health services research and pharmacy practice was held in Birmingham in June, organised by the Pharmacy Practice Research Resource Centre. There were around 100 participants, including several from overseas     

Adaptability,Agency, and Association to Influence Change: The Report of the 2020-21 AACP Argus Commission

EXECUTIVE SUMMARY The 2020-21 AACP Argus Commission was charged to 1) review the 2019-2020 standing committee reports; 2) describe the impact of COVID-19 on healthcare delivery with an emphasis on health equity and social justice, 3) identify strategies to work with other health professions associations to advance interprofessional education and practice, and 4) offer recommendations for activities for the Center to Accelerate Pharmacy Practice Transformation and Academic Innovation (CAPT). Two work groups divided charges 2 and 3 and provided assessments of how health care and education might change due to all we have experienced over the 12-plus months of the pandemic. A review of plans for the first year of the CAPT activities and recommendations for additional activities are included in report. The Commission has proposed two new policy statements on digital health, five recommendations for AACP and five suggestions for colleges and schools of pharmacy. The Argus Commission affirms academic pharmacy’s adaptability, agency, and association to influence changes in healthcare delivery and interprofessional education and practice.     

Explanations and unresolved issues pertaining to the development of the Nuclear Pharmacy Compounding Guidelines

OBJECTIVES: To provide background information related to the development of the Nuclear Pharmacy Compounding Guidelines, to discuss regulatory complexities related to radiopharmaceutical compounding practice, and to summarize the gaps in the current compounding regulations for radiopharmaceuticals. DATA SOURCES: The Guidelines closely follow the provisions of section 503A of the Federal Food, Drug, and Cosmetic Act (FD&C Act), the monographs and chapters related to pharmacy compounding in the United States Pharmacopeia (USP), and the recommended guidelines published by the American Society of Health-System Pharmacists. SUMMARY: The Food and Drug Administration Modernization Act (FDAMA) of 1997 established parameters under which the compounding of drug products is appropriate and lawful, but these criteria expressly do not apply to radiopharmaceuticals. The Nuclear Pharmacy Compounding Practice Committee, a group of nuclear pharmacists convened by the American Pharmaceutical Association, developed the Nuclear Pharmacy Compounding Guidelines to establish a set of principles and guidelines for good radiopharmaceutical compounding practice. The intent of the new document is to provide guidance on radiopharmaceutical compounding practices that have evolved over the last 2 decades and to place them in an appropriate regulatory framework in accordance with previous enforcement policies and guidelines issued by the U.S. Food and Drug Administration (FDA) regarding the exemption of certain pharmacy practices from enforcement of adulteration, misbranding, and new drug requirements. CONCLUSION: The Nuclear Pharmacy Compounding Guidelines, recently released by APhA, is the first official document that provides realistic and practical compounding guidance for nuclear pharmacists. Even though the United States Court of Appeals for the Ninth Circuit recently ruled section 503A of the FD&C Act to be invalid in its entirety, and the Supreme Court upheld that ruling, the compliance policy guides issued by FDA in March 1992 and revised in May 2002 maintain guiding principles on pharmacy compounding similar to those stated in section 503A of the FD&C Act. The Nuclear Pharmacy Compounding Practice Committee is optimistic that the practical information contained in the Guidelines will assist state boards of pharmacy, FDA, and the United States Pharmacopeial Convention in setting appropriate standards for nuclear pharmacy compounding practice that will ensure the continued availability of high-quality compounded radiopharmaceuticals at reasonable cost.     

“Before the training I just assumed they've done something bad”: Reporting on professional training for pharmacy assistants and pharmacy dispensary technicians on medically assisted treatment of opioid dependence

BackgroundA study that examined the lived experiences of Medically Assisted Treatment of Opioid Dependence (MATOD) consumers suggested that they had experienced discrimination and stigma in pharmacies in regional Victoria, Australia. To address this, the need for professional training opportunities for Pharmacy Assistants (PAs) and Pharmacy Dispensary Technicians (PTDs) had been emphasised. A research project was undertaken to develop training modules using Social Determinants of Health (SDH) for PAs and PDTs involved in providing MATOD pharmacy services in regional Victoria, and to evaluate their effectiveness.ObjectivesThe study aimed to examine and evaluate changes in attitudes and practices amongst PAs and PDTs involved in MATOD services in regional Victoria, Australia and who had undertaken the training modules.MethodsThe paper reports primarily on the in-depth qualitative interviews that were completed after the training with PAs and PTDs. Thematic analysis was employed to code the data.ResultsThematic analysis generated five themes: understanding of the professional role of PAs and PTDs, initial judgements concerning MATOD consumers, reflection on the SDH, training content analysis, and the post-training impact upon Professional Practice. These themes reflected participants’ insights with regards both to MATOD consumers and the impact the training itself had had on their professional practice.Conclusion“Consciousness-raising” from participation in the training can positively influence the development of participants’ professional attitudes and practices with regards to MATOD service delivery. This development supports that training informed by SDH and ideas of critical reflection can help facilitate the creation of knowledge around the social construction of health and increased understanding of the impacts of language-use, attitudes and behaviour.     

药理学课程教学改革探析

药理学是BTEC(英国商业与技术教育委员会)生物药学与生物技术及应用专业的一门应用基础课程,是培养实用的服务型生物药学人才必不可少的基本内容。介绍BTEC药理学教学的特点,分析教学过程中存在的问题,对调整和更新药理学教学内容提出有针对性的建议,强调应用开放式系统教学法、行为引导教学法等教法培养学生对药理学的实际应用能力,使药理学课程的理论教学与实际应用紧密衔接。